Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of proteome research"
DOI: 10.1021/acs.jproteome.1c00980
Abstract: Tyrosine kinases (TKs) are prominent targets in cancer therapies, and more than 30 TK inhibitors have been approved for treatments in tumors with abnormal TK. Disappointingly, an incomplete response can occur with the long-term use…
read more here.
Keywords:
tyrosine kinases;
activity;
resistance;
activity representing ... See more keywords